Showing results (181-190 of 259) with videos related to
Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Comparison of Posttherapy 4- and 24-Hour [<sup>177</sup>Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate CancerMina Swiha, Sarennya Pathmanandavel, Nathan Papa, et al.Journal for Immunotherapy of Cancer|November 10, 2019
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR statusFotios Loupakis, Giulia Maddalena, Ilaria Depetris, et al.JCO Clinical Cancer Informatics|April 22, 2024
Explainable Machine Learning Model to Preoperatively Predict Postoperative Complications in Inpatients With Cancer Undergoing Major OperationsMatthew C Hernandez, Chen Chen, Andrew Nguyen, et al.Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|May 9, 2023
Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature ReviewNaomie Devico Marciano, Ryan S Beyer, Andrew Nguyen, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2022
<sup>64</sup>Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I TrialKeith Wong, Gemma Sheehan-Dare, Andrew Nguyen, et al.Journal of Medical Imaging and Radiation Oncology|October 22, 2021
Diagnostic value of <sup>68</sup> Ga-DOTATATE PET-CT imaging for staging of ER<sup>+</sup> /PR<sup>+</sup> HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and <sup>18</sup> F-FDG PET-CT in a prospective pilot trialAndrew Nguyen, Karen Fullard, Gemma Sheehan-Dare, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to <sup>177</sup>Lu-Prostate-Specific Membrane Antigen TherapyShejil Kumar, Megan Crumbaker, Christopher Harvey, et al.Mbio|June 5, 2014
Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosisParas Jain, Tsungda Hsu, Masayoshi Arai, et al.Journal of Neurosurgery. Case Lessons|September 1, 2022
Surgical treatment in primary spinal infections in a pediatric population: illustrative caseRyan S Beyer, Austin J Franklin, Matthew J Hatter, et al.World Neurosurgery|February 10, 2023
Analysis of Current Neurological Surgery Residents and Prior Medical Education: Do Medical School Attributes Matter?Gabrielle E A Hovis, Mark H Harris, Andrew Nguyen, et al.Pageof 26